← Back to Clinical Trials
Recruiting NCT05401669

NCT05401669 Transradial Versus Transfemoral Access for Cerebral Angiography

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05401669
Status Recruiting
Phase
Sponsor Huashan Hospital
Condition Cerebral Angiography
Study Type INTERVENTIONAL
Enrollment 748 participants
Start Date 2023-09-15
Primary Completion 2024-10-20

Trial Parameters

Condition Cerebral Angiography
Sponsor Huashan Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 748
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2023-09-15
Completion 2024-10-20
Interventions
Trans-radial accessTrans-femoral access

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study is multi-center, prospective, randomized (1:1) controlled trial designed to assess and compare the feasibility, safety and success of Transradial access (TRA) versus Transfemoral access (TFA) for diagnostic cerebral angiography.

Eligibility Criteria

Inclusion Criteria: 1. Age between 18 and 80 years old; 2. Scheduled to undergo diagnostic cerebral angiography; 3. Suitable for cerebral angiography via TRA and TFA access, with a radial artery diameter ≥2mm confirmed by ultrasonography; 4. Modified Rankin Scale (mRS) score ≤2; 5. Provided written informed consent. Exclusion Criteria: 1. Severe stenosis of the radial, brachial, subclavian, brachiocephalic, iliac or common femoral arteries, or any significant vascular disease (such as aortic aneurysm, etc.) that may obstruct guidewire passage; 2. Arteriovenous fistula for hemodialysis present in the right upper limb; 3. Planned interventional surgery within 24 hours of the initial study angiography; 4. Requirement for cerebral angiography in an emergency department; 5. Use of general anesthesia; 6. Any contraindication to cerebral angiography, such as allergy or intolerance to the contrast media, uncorrected severe coagulation disorders, arterial dissection in the target vessel, punctu

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology